How many FDA actions has Rising Pharma Holding, Inc. had?

Argus HQ has recorded 1 FDA events for Rising Pharma Holding, Inc.: 0 warning letters, 1 recalls, 0 approvals, and 0 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

What is the most recent FDA action against Rising Pharma Holding, Inc.?

The most recent FDA event Argus HQ has on file for Rising Pharma Holding, Inc. is dated 2026-07-29, with a severity rating of "high" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Does Argus HQ track new FDA actions for Rising Pharma Holding, Inc. automatically?

Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Rising Pharma Holding, Inc. is observed, this page's event count and history update automatically.

How many FDA actions does Argus HQ track for Rising Pharma Holding, Inc.?

1 total: 0 warning letters, 1 recall, 0 approval records, and 0 Form 483 inspection citations.

Rising Pharma Holding, Inc. — FDA Compliance Timeline

Here's the summary: Argus HQ has recorded 1 FDA events for Rising Pharma Holding, Inc.: 0 warning letters, 1 recalls, 0 approvals, and 0 inspection 483 observations. These events span from 2026-07-29 to 2026-07-29. The most severe rating Argus HQ has assigned across this history is "high". Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

FDA action counts

Total FDA actions	1
Warning letters	0
Recalls	1
Approval records	0
Form 483 inspection citations	0
Most recent action	July 29, 2026

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. Rising Pharma Holding, Inc. has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Enforcement history

On 2026-07-29, Argus HQ recorded an FDA recall for Rising Pharma Holding, Inc., rated "high" severity in Argus HQ's classification: Rising Pharma Holding, Inc. — Class II recall: Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only…. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Frequently asked questions

How many FDA actions has Rising Pharma Holding, Inc. had?: Argus HQ has recorded 1 FDA events for Rising Pharma Holding, Inc.: 0 warning letters, 1 recalls, 0 approvals, and 0 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
What is the most recent FDA action against Rising Pharma Holding, Inc.?: The most recent FDA event Argus HQ has on file for Rising Pharma Holding, Inc. is dated 2026-07-29, with a severity rating of "high" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Does Argus HQ track new FDA actions for Rising Pharma Holding, Inc. automatically?: Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Rising Pharma Holding, Inc. is observed, this page's event count and history update automatically.
How many FDA actions does Argus HQ track for Rising Pharma Holding, Inc.?: 1 total: 0 warning letters, 1 recall, 0 approval records, and 0 Form 483 inspection citations.

Every FDA action tied to this company, the week it happens.

Free weekly briefing. Real-time alerts on paid plans.

Rising Pharma Holding, Inc. — Class II recall: Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only… →

Compare with

Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Verified from FDA.gov · Last updated: Jul 29, 2026

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). Rising Pharma Holding, Inc. — FDA Compliance Timeline. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/company/rising-pharma-holding-inc

MLA

"Rising Pharma Holding, Inc. — FDA Compliance Timeline." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/company/rising-pharma-holding-inc.

Chicago

Argus HQ Research. "Rising Pharma Holding, Inc. — FDA Compliance Timeline." Digital Empire Holdings LLC. Accessed August 4, 2026. https://argushq.ai/company/rising-pharma-holding-inc.

BibTeX

@misc{argushq_argushq_ai_company_rising_pharma_holding_inc_2026,
  title = {Rising Pharma Holding, Inc. — FDA Compliance Timeline},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/company/rising-pharma-holding-inc},
  note = {Accessed: August 4, 2026}
}

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗